Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Response to antiplatelet treatment: from genes to outcome.

Lancet (London, England) - 16 Oct 2010

Giusti Betti, Abbate Rosanna

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Coronary Syndrome
Share to Angioplasty, Balloon, Coronary
Share to Aspirin
Share to Clopidogrel

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prasugrel Hydrochloride

Share to Stents

Share to Thiophenes

Share to Ticlopidine

Source

Identifiers

PMID: 20801497
DOI: 10.1016/S0140-6736(10)61313-X

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Response to antiplatelet treatment: from genes to outcome.PMID 20801497Read ↗

The ABCD-GENE score influences vascular event rates in both users of clopidogrel and aspirin, as well as non-users of either drug in a population-based cohort studySemantic proximity Read ↗

Clopidogrel pharmacogenomics: next steps: a clinical algorithm, gene-gene interactions, and an elusive outcomes trial.Semantic proximity Read ↗

Clopidogrel and Genotyping.Semantic proximity Read ↗

Give genotype-guided dual antiplatelet therapy a second CHANCE.Semantic proximity Read ↗

Clopidogrel in acute coronary syndrome: to genotype or not?Semantic proximity Read ↗

Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points—Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)Semantic proximity Read ↗

Genotype-Guided Antiplatelet Therapy After Coronary Intervention in Patients With High Bleeding Risk - Never Judge a Book by Its Cover.Semantic proximity Read ↗

Aspirin protects some hearts better than others. It's in the genes. A biomarker can predict a person's response to this potentially lifesaving medication.Semantic proximity Read ↗

Using Pharmacogenetic Testing or Platelet Reactivity Testing to Tailor Antiplatelet Therapy: Are Asians different from Caucasians?Semantic proximity Read ↗

Effect of pharmacogenomics - oriented Dual Antiplatelet Therapy Followed by P2Y12 receptor inhibitors/Aspirin on Cardiovascular and Bleeding Events in ACS Patients: A Trial ProtocolSemantic proximity Read ↗

Molecular genomic and epigenomic characteristics related to aspirin and clopidogrel resistanceSemantic proximity Read ↗

The pharmacogenetics of antiplatelet agents: towards personalized therapy?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.